119 related articles for article (PubMed ID: 26636525)
1. Activin A as a novel biomarker for colorectal adenocarcinoma in humans.
Wu S; Qi Y; Niu LM; Xie DX; Cui XL; Liu ZH
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4371-8. PubMed ID: 26636525
[TBL] [Abstract][Full Text] [Related]
2. Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer.
Refaat B; El-Shemi AG; Mohamed AM; Kensara OA; Ahmad J; Idris S
BMC Cancer; 2016 Nov; 16(1):879. PubMed ID: 27835986
[TBL] [Abstract][Full Text] [Related]
3. The role of neurotensin as a novel biomarker in the endoscopic screening of high-risk population for developing colorectal neoplasia.
Kontovounisios C; Qiu S; Rasheed S; Darzi A; Tekkis P
Updates Surg; 2017 Sep; 69(3):397-402. PubMed ID: 28560510
[TBL] [Abstract][Full Text] [Related]
4. Comparison of colorectal neoplastic polyps and adenocarcinoma with regard to NLR and PLR.
Emir S; Aydin M; Can G; Bali I; Yildirim O; Öznur M; Yildiz ZD; Sözen S; Gürel A
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3613-8. PubMed ID: 26502851
[TBL] [Abstract][Full Text] [Related]
5. Serum and tissue expression of activin a in postmenopausal women with breast cancer.
Reis FM; Cobellis L; Tameirão LC; Anania G; Luisi S; Silva IS; Gioffrè W; Di Blasio AM; Petraglia F
J Clin Endocrinol Metab; 2002 May; 87(5):2277-82. PubMed ID: 11994376
[TBL] [Abstract][Full Text] [Related]
6. High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.
Hoda MA; Rozsas A; Lang E; Klikovits T; Lohinai Z; Torok S; Berta J; Bendek M; Berger W; Hegedus B; Klepetko W; Renyi-Vamos F; Grusch M; Dome B; Laszlo V
Oncotarget; 2016 Mar; 7(12):13388-99. PubMed ID: 26950277
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss.
Talar-Wojnarowska R; Wozniak M; Borkowska A; Olakowski M; Malecka-Panas E
J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32554845
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer.
Ozemir IA; Aslan S; Eren T; Bayraktar B; Bilgic C; Isbilen B; Yalman H; Yigitbasi R; Alimoglu O;
Chirurgia (Bucur); 2016; 111(5):414-421. PubMed ID: 27819647
[TBL] [Abstract][Full Text] [Related]
11. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.
Baraniskin A; Nöpel-Dünnebacke S; Ahrens M; Jensen SG; Zöllner H; Maghnouj A; Wos A; Mayerle J; Munding J; Kost D; Reinacher-Schick A; Liffers S; Schroers R; Chromik AM; Meyer HE; Uhl W; Klein-Scory S; Weiss FU; Stephan C; Schwarte-Waldhoff I; Lerch MM; Tannapfel A; Schmiegel W; Andersen CL; Hahn SA
Int J Cancer; 2013 Jan; 132(2):E48-57. PubMed ID: 22907602
[TBL] [Abstract][Full Text] [Related]
12. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
[TBL] [Abstract][Full Text] [Related]
13. S100P, a potential novel prognostic marker in colorectal cancer.
Wang Q; Zhang YN; Lin GL; Qiu HZ; Wu B; Wu HY; Zhao Y; Chen YJ; Lu CM
Oncol Rep; 2012 Jul; 28(1):303-10. PubMed ID: 22552710
[TBL] [Abstract][Full Text] [Related]
14. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
15. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract][Full Text] [Related]
16. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
[TBL] [Abstract][Full Text] [Related]
17. Serum AMDL DR-70 levels: a new concept in the diagnosis and follow-up of colorectal carcinoma.
Saridemir S; Güven HE; Aksel B; Doğan L
Biomark Med; 2020 Jun; 14(8):621-628. PubMed ID: 32608998
[No Abstract] [Full Text] [Related]
18. Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.
Li Q; Wang K; Su C; Fang J
Technol Cancer Res Treat; 2017 Aug; 16(4):440-445. PubMed ID: 27760866
[TBL] [Abstract][Full Text] [Related]
19. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
